FATE
#3196
Fate Therapeutics, Inc. - Common Stock
2.9 9 USD
-0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.99%
Monthly Change
+43.06%
6 month change
+179.44%
Year Change
+160.00%
Previous Close
3.0 2
Open
3.0 2
Low
2.9 7
High
3.0 4
Volume
766
Financials
- Market Capitalization 348.51 M
- Employee 161
- Founded 2007
- CEO Scott Wolchko
- Website www.fatetherapeutics.com
- Headquarter California, United States
- FIGI BBG000QP35H2
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.85
Price to sales ratio
17.56
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3146 |  AVIR Atea Pharmaceuticals, Inc. - common stock | 4.71 USD | -0.63% | -3.48% | +5.61% | +46.73% | 376.93 M USD | ||
| 3152 |  LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.63 USD | -0.43% | -3.34% | +2.21% | +2.89% | 363.56 M USD | ||
| 3198 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 4.39 USD | -1.13% | -11.67% | -4.57% | +441.98% | 349.64 M USD | ||
| 3200 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.85 USD | -2.50% | -8.45% | -1.35% | +5.79% | 351.79 M USD |
Frequently asked questions about Fate Therapeutics, Inc. - Common Stock
What is the Fate Therapeutics, Inc. - Common Stock stock price today?
The current price of Fate Therapeutics, Inc. - Common Stock (FATE) is 2.99. Over the past 24 hours, the stock has changed by -0.99%. Follow the FATE chart for real-time price dynamics.
What is the stock ticker of Fate Therapeutics, Inc. - Common Stock?
Fate Therapeutics, Inc. - Common Stock trades under the ticker FATE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Fate Therapeutics, Inc. - Common Stock stock going up?
FATE has changed by -0.99% over the last week, +43.06% over the last month, and +160.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Fate Therapeutics, Inc. - Common Stock net income for the last quarter?
Fate Therapeutics, Inc. - Common Stock reported net income of -31.21 M for the last quarter. The previous quarter showed -32.37 M, which means net income changed by +3.59%.
How many employees does Fate Therapeutics, Inc. - Common Stock have?
As of the latest available data, Fate Therapeutics, Inc. - Common Stock has 161 employees. Workforce size can provide additional context about the company's scale and operations.
What is Fate Therapeutics, Inc. - Common Stock EBITDA?
Fate Therapeutics, Inc. - Common Stock EBITDA is -30.08 M, and its EBITDA margin is -2 315.78%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Fate Therapeutics, Inc. - Common Stock stock?
You can buy Fate Therapeutics, Inc. - Common Stock (FATE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Fate Therapeutics, Inc. - Common Stock stock?
Investing in Fate Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the FATE chart and related analysis on metatrader.com as part of your research.